RENOVATIONS HAVE BEEN UNDERWAY HERE AT GRACE MEDICAL CENTER SINCE 2020, BUT THEY HAVEN’T BEEN ABLE TO SHOW ANYONE THE PROGRESS BECAUSE OF THE PANDEMIC. WELL, NOW THEY’RE EXCITED TO SHOW PEOPLE ...

April 15 (Reuters) - The European Commission on Tuesday authorized the use of Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab drug to treat some patients with mild cognitive ...

Against Nemaha Central earlier in the season, Hayden’s Cooper Grace stood at third base. A ball rocketed towards him and he was unable to cleanly grab the tough grounder. He snagged the ball ...

WINONA LAKE, Ind. (WNDU) - Grace College is taking on a major project in the 2025 Baja SAE International Engineering Competition. Grace’s team will compete against nearly 80 other schools to ...

Natalia Grace was allegedly born in Mykolaiv, Ukraine, on September 4, 2003. She was born with a rare form of dwarfism, and that’s believed to be the reason her birth mother gave her up.

Huddle up, Hunger Games fans — casting news coming at you hot off the Panem press! As fans of Suzanne Collins' wildly popular win-or-die YA book series will be well aware, last month saw the ...

Eisai has set Leqembi’s price at $26,500 per year in the US. It’s estimated to cost ¥2.98 million ($20,929) annually in Japan, based on government pricing. 0 ...

Another tribute has been chosen. The new “Hunger Games” prequel “Sunrise on the Reaping” has cast Mckenna Grace as Maysilee Donner, one of the tributes from District 12 alongside lead ...

Mckenna Grace has been cast as Maysilee Donner in ‘The Hunger Games: Sunrise on the Reaping.' Everything you need to know about the actress. Actress and singer Mckenna Grace has been cast as ...

In this as-told-to essay, singer and songwriter Grace VanderWaal talks to associate culture director P. Claire Dodson about her new album Child Star, its short film performance piece, and growing ...

Eisai leads lecanemab’s development and regulatory submissions globally. Biogen and Eisai co-commercialize and co-promote the product. Eisai has final decision-making authority. In the EU ...

Biogen and Eisai’s Alzheimer’s disease (AD) drug Leqembi (lecanemab) has been approved by the European Commission (EC). The decision makes Leqembi the first therapy authorised in the EU that targets ...